ACR Gears Up For Key State Legislative Issues Including AI
ACR joined physician leaders at the AMA summit to address Medicaid, payer issues, physician-led care, wellness, and emerging AI legislation in states.
Read more
ACR® is developing comments in response to a U.S. Department of Health and Human Services (HHS) Request for Information (RFI) that seeks input on topics including clinical AI regulation, reimbursement, and research and development to advance AI used in patient care.
Specifically, HHS is interested in learning about how these areas of federal influence can be leveraged to encourage clinical AI adoption and use, foster public trust and confidence, improve policy clarity, and align federal incentives. The RFI features a series of broad discussions followed by targeted questions for stakeholders' consideration.
If you have questions or would like to provide input to be considered for ACR’s response to the RFI, contact Michael Peters, Senior Director, Government Affairs, Lindsay Robbins, Regulatory Policy Specialist, or Christina Berry, Team Lead, Economic Policy.
ACR Gears Up For Key State Legislative Issues Including AI
ACR joined physician leaders at the AMA summit to address Medicaid, payer issues, physician-led care, wellness, and emerging AI legislation in states.
Read more
FDA Updates Guidance on Clinical Decision Support
FDA’s 2026 CDS update clarifies which software is regulated, affirming oversight of image‑analysis tools while exempting certain guideline‑based CDS.
Read moreStates Begin to Introduce Bills for 2026
States launch 2026 sessions with new bills on AI governance, rural radiation therapy, imaging workforce standards, and dose rules.
Read more